These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 25401049)

  • 1. New Insights on Glucosylceramide Synthase in Cancer Drug Resistance and Myelosuppression.
    Gupta V; Liu YY
    Biochem Pharmacol (Los Angel); 2013 Sep; 2():. PubMed ID: 25401049
    [No Abstract]   [Full Text] [Related]  

  • 2. Therapeutic potential of targeting ceramide/glucosylceramide pathway in cancer.
    Kartal Yandım M; Apohan E; Baran Y
    Cancer Chemother Pharmacol; 2013 Jan; 71(1):13-20. PubMed ID: 23073611
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early developmental expression of the gene encoding glucosylceramide synthase, the enzyme controlling the first committed step of glycosphingolipid synthesis.
    Yamashita T; Wada R; Proia RL
    Biochim Biophys Acta; 2002 Dec; 1573(3):236-40. PubMed ID: 12417405
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multidrug resistance modulators and doxorubicin synergize to elevate ceramide levels and elicit apoptosis in drug-resistant cancer cells.
    Lucci A; Han TY; Liu YY; Giuliano AE; Cabot MC
    Cancer; 1999 Jul; 86(2):300-11. PubMed ID: 10421266
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of glucosylceramide synthase eliminates the oncogenic function of p53 R273H mutant in the epithelial-mesenchymal transition and induced pluripotency of colon cancer cells.
    Hosain SB; Khiste SK; Uddin MB; Vorubindi V; Ingram C; Zhang S; Hill RA; Gu X; Liu YY
    Oncotarget; 2016 Sep; 7(37):60575-60592. PubMed ID: 27517620
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glycosphingolipids and drug resistance.
    Gouaze-Andersson V; Cabot MC
    Biochim Biophys Acta; 2006 Dec; 1758(12):2096-103. PubMed ID: 17010304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glucosylceramide synthase and glycosphingolipid synthesis.
    Ichikawa S; Hirabayashi Y
    Trends Cell Biol; 1998 May; 8(5):198-202. PubMed ID: 9695839
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glycosphingolipid depletion in fabry disease lymphoblasts with potent inhibitors of glucosylceramide synthase.
    Abe A; Arend LJ; Lee L; Lingwood C; Brady RO; Shayman JA
    Kidney Int; 2000 Feb; 57(2):446-54. PubMed ID: 10652021
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Iminosugar-based inhibitors of glucosylceramide synthase prolong survival but paradoxically increase brain glucosylceramide levels in Niemann-Pick C mice.
    Nietupski JB; Pacheco JJ; Chuang WL; Maratea K; Li L; Foley J; Ashe KM; Cooper CG; Aerts JM; Copeland DP; Scheule RK; Cheng SH; Marshall J
    Mol Genet Metab; 2012 Apr; 105(4):621-8. PubMed ID: 22366055
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glucosylceramide in humans.
    Messner MC; Cabot MC
    Adv Exp Med Biol; 2010; 688():156-64. PubMed ID: 20919653
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The absence of functional glucosylceramide synthase does not sensitize melanoma cells for anticancer drugs.
    Veldman RJ; Mita A; Cuvillier O; Garcia V; Klappe K; Medin JA; Campbell JD; Carpentier S; Kok JW; Levade T
    FASEB J; 2003 Jun; 17(9):1144-6. PubMed ID: 12692077
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Can P-glycoprotein influence the bioavailability of iminosugar-based glucosylceramide synthase inhibitors?
    Norris-Cervetto E; Butters TD; Martin C; Modok S; Dwek RA; Callaghan R
    Eur J Pharmacol; 2006 Jan; 530(3):195-204. PubMed ID: 16403499
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incorporation of Fluorescence Ceramide-Based HPLC Assay for Rapidly and Efficiently Assessing Glucosylceramide Synthase In Vivo.
    Khiste SK; Hosain SB; Dong Y; Uddin MB; Roy KR; Hill RA; Liu Z; Liu YY
    Sci Rep; 2017 Jun; 7(1):2976. PubMed ID: 28592871
    [TBL] [Abstract][Full Text] [Related]  

  • 14. UDP-glucose ceramide glucosyltransferase activates AKT, promoted proliferation, and doxorubicin resistance in breast cancer cells.
    Wegner MS; Schömel N; Gruber L; Örtel SB; Kjellberg MA; Mattjus P; Kurz J; Trautmann S; Peng B; Wegner M; Kaulich M; Ahrends R; Geisslinger G; Grösch S
    Cell Mol Life Sci; 2018 Sep; 75(18):3393-3410. PubMed ID: 29549423
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A specific and potent inhibitor of glucosylceramide synthase for substrate inhibition therapy of Gaucher disease.
    McEachern KA; Fung J; Komarnitsky S; Siegel CS; Chuang WL; Hutto E; Shayman JA; Grabowski GA; Aerts JM; Cheng SH; Copeland DP; Marshall J
    Mol Genet Metab; 2007 Jul; 91(3):259-67. PubMed ID: 17509920
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glucosylceramide synthase inhibitors differentially affect expression of glycosphingolipids.
    Alam S; Fedier A; Kohler RS; Jacob F
    Glycobiology; 2015 Apr; 25(4):351-6. PubMed ID: 25715344
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glycosphingolipids in Plasmodium falciparum. Presence of an active glucosylceramide synthase.
    Couto AS; Caffaro C; Uhrig ML; Kimura E; Peres VJ; Merino EF; Katzin AM; Nishioka M; Nonami H; Erra-Balsells R
    Eur J Biochem; 2004 Jun; 271(11):2204-14. PubMed ID: 15153110
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kidney glycosphingolipids are elevated early in diabetic nephropathy and mediate hypertrophy of mesangial cells.
    Subathra M; Korrapati M; Howell LA; Arthur JM; Shayman JA; Schnellmann RG; Siskind LJ
    Am J Physiol Renal Physiol; 2015 Aug; 309(3):F204-15. PubMed ID: 26041445
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glucosylceramide synthase: assay and properties.
    Shayman JA; Abe A
    Methods Enzymol; 2000; 311():42-9. PubMed ID: 10563309
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression of glucosylceramide synthase in associated with multidrug resistance of leukemia cells.
    Xie P; Shen YF; Shi YP; Ge SM; Gu ZH; Wang J; Mu HJ; Zhang B; Qiao WZ; Xie KM
    Leuk Res; 2008 Mar; 32(3):475-80. PubMed ID: 17709137
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.